Squamous cell carcinoma in a psoriasis patient possibly due to long-term methotrexate
Squamous cell carcinoma (SCC) in a patient of psoriasis is a rare occurrence with paramount clinical significance for selecting the appropriate management options. We report a case of SCC in a 45-year-old male patient of psoriasis on unsupervised methotrexate for over 10 years. This case report high...
Main Authors: | Guneet Awal, Manpreet Kaur, Ravika Kanish Budhiraja |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Drugs in Dermatology |
Subjects: | |
Online Access: | http://www.ijdd.in/article.asp?issn=2455-3972;year=2017;volume=3;issue=2;spage=84;epage=86;aulast=Awal |
Similar Items
-
Tratamento sistêmico da psoríase - Parte I: metotrexato e acitretina Systemic treatment of psoriasis - Part I: methotrexate and acitretin
by: Gladys Aires Martins, et al.
Published: (2004-05-01) -
Methotrexate Use for Patients with Psoriasis and Risk of Cutaneous Squamous Cell Carcinoma: A Nested Case-control Study
by: Filippos Giannopoulos, et al.
Published: (2021-01-01) -
SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
by: L. S. Namazova-Baranova, et al.
Published: (2017-10-01) -
Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
by: Mahé E
Published: (2020-11-01) -
Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
by: Julita Anna Krahel, et al.
Published: (2020-03-01)